Abstract:ObjectiveEncapsulation of esculetin into DSPE-MPEG2000 carrier was performed to improve its water solubility and oral bioavailability, as well as enhance its anti-inflammatory effect on a mouse model of ulcerative colitis that was induced with dextran sulphate sodium (DSS).MethodsWe determined the in-vitro and in-vivo high-performance liquid chromatographic (HPLC) analysis method of esculetin; Esculetin-loaded nanostructure lipid carrier (Esc-NLC) was prepared using a thin-film dispersion method, wherein a particle size analyser was used to measure the particle size (PS) and zeta potential (ZP) of the Esc-NLC, while a transmission electron microscope (TEM) was employed to observe its morphology. Also, HPLC was used to measure its drug loading (DL), encapsulation efficiency (EE) and the in-vitro release of the preparation, as well as investigate the pharmacokinetic parameters. In addition, its anti-colitis effect was evaluated via histopathological examination of HE-stained sections and detection of the concentrations of tumour necrosis factor-alpha (TNF-alpha), interleukin (IL)-1 beta (beta), and IL-6 in serum with ELISA kits.ResultsThe PS of Esc-NLC was 102.29 +/- 0.63 nm with relative standard deviation (RSD) of 1.08% (with poly-dispersity index-PDI of 0.197 +/- 0.023), while the ZP was -15.67 +/- 1.39 mV with RSD of 1.24%. Solubility of esculetin was improved coupled with prolonged release time. Its pharmacokinetic parameters were compared with that of free esculetin, wherein the maximum concentration of the drug in plasma was increased by 5.5 times. Of note, bioavailability of the drug was increased by 1.7 times, while the half-life was prolonged by 2.4 times. In the anti-colitis efficacy experiment, the mice in Esc and Esc-NLC groups exhibited significantly reduced levels of TNF-alpha, IL-1 beta, and IL-6 in their sera comparable to the DSS group. Colon histopathological examination revealed that mice with ulcerative colitis in both Esc and Esc-NLC groups displayed improved inflammation, amid the Esc-NLC groups having the best prophylactic treatment effect.ConclusionEsc-NLC could ameliorate DSS-induced ulcerative colitis by improving bioavailability, prolonging drug release time and regulating cytokine release. This observation confirmed the potential of Esc-NLC to reduce inflammation in ulcerative colitis, albeit the need for follow-up research to verify the application of this strategy to clinical treatment of ulcerative colitis.

Preparation and protective effects of 1,8-cineole-loaded self-microemulsifying drug delivery system on lipopolysaccharide-induced endothelial injury in mice.

Oral Bioavailability and Lymphatic Transport of Pueraria Flavone-Loaded Self-Emulsifying Drug-Delivery Systems Containing Sodium Taurocholate in Rats.

Diethylaminoethyl-dextran and monocyte cell membrane coated 1,8-cineole delivery system for intracellular delivery and synergistic treatment of atherosclerosis

Ameliorating Effects of 1,8-Cineole on LPS-induced Human Umbilical Vein Endothelial Cell Injury by Suppressing NF-κB Signaling in Vitro.

1,8-Cineole Ameliorates LPS-Induced Vascular Endothelium Dysfunction in Mice Via PPAR-γ Dependent Regulation of NF-κB

Enhanced Protective Activity of 1,8-Cineole on Emphysema Using Hyaluronic Acid-Coated Liposomes Via Quantitative Pulmonary Administration in Mice

Polysialic acid driving cardiovascular targeting co-delivery 1,8-cineole and miR-126 to synergistically alleviate lipopolysaccharide-induced acute cardiovascular injury

Improved Oral Bioavailability and Hypolipidemic Effect of Syringic Acid via a Self-microemulsifying Drug Delivery System

SMEDDS for improved oral bioavailability and anti-hyperuricemic activity of licochalcone A

Fabrication of a Polysaccharide-Protein/Protein Complex Stabilized Oral Nanoemulsion to Facilitate the Therapeutic Effects of 1,8-Cineole on Atherosclerosis

In-vitro and In-Vivo Evaluation and Anti-Colitis Activity of Esculetin-Loaded Nanostructured Lipid Carrier Decorated with DSPE-MPEG2000.

Mucoadhesive liposomal delivery system synergizing anti-inflammation and anti-oxidation for enhanced treatment against dry eye disease

Preventive Effect of Coptis Chinensis and Berberine on Intestinal Injury in Rats Challenged with Lipopolysaccharides

Preparation, characterization, ex vivo transdermal properties and skin irritation evaluation of 1,8-cineole nanoemulsion gel

Pre-treatment with Compound Danshen Dripping Pills Prevents Lipid Infusion-Induced Microvascular Dysfunction in Mice

Improved Oral Bioavailability of Myricitrin by Liquid Self-Microemulsifying Drug Delivery Systems

Protective effect of Chrysanthemum morifolium Ramat. ethanol extract on lipopolysaccharide induced acute lung injury in mice

Self-Micro-Emulsifying Controlled Release of Eugenol Pellets: Preparation, in Vitro/in Vivo Investigation in Beagle Dogs.

Enhanced Oral Bioavailability of [6]-Gingerol-smedds: Preparation, in Vitro and in Vivo Evaluation

Enhancement of oral absorption of curcumin by self-microemulsifying drug delivery systems.

Cavidine Ameliorates Lipopolysaccharide-Induced Acute Lung Injury Via NF-κB Signaling Pathway in Vivo and in Vitro